Engineered in-situ depot-forming hydrogels for intratumoral drug delivery.

Fakhari, Amir; Anand Subramony, J

Fakhari, Amir; Anand Subramony, J.

Affiliation

Fakhari A; Drug Delivery and Device Development, Medimmune LLC, United States.
Anand Subramony J; Drug Delivery and Device Development, Medimmune LLC, United States. Electronic address: subramonya@medimmune.com.

J Control Release ; 220(Pt A): 465-475, 2015 Dec 28.

Article in En | MEDLINE | ID: mdl-26585504

Subject(s)

Antineoplastic Agents/administration & dosage; Drug Carriers; Genetic Therapy/methods; Neoplasms/therapy; Oncolytic Virotherapy/methods; Oncolytic Viruses; Polymers/chemistry; Animals; Antineoplastic Agents/chemistry; Antineoplastic Agents/metabolism; Delayed-Action Preparations; Drug Compounding; Humans; Hydrogels; Injections, Intralesional; Neoplasms/genetics; Neoplasms/metabolism; Neoplasms/virology; Oncolytic Viruses/genetics; Oncolytic Viruses/metabolism

Key words

Anticancer drug; Biologics sustained release; Engineered hydrogel; In-situ gelling; Intratumoral drug delivery

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polymers / Drug Carriers / Genetic Therapy / Oncolytic Viruses / Oncolytic Virotherapy / Neoplasms / Antineoplastic Agents Limits: Animals / Humans Language: En Journal: J Control Release Journal subject: FARMACOLOGIA Year: 2015 Document type: Article Affiliation country: United States Country of publication: Netherlands

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google